Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated with Decreased Mortality in Japanese Malignant Hyperthermia Events.
Yukari ToyotaTakashi KondoDaiki ShorinAyako SumiiKenshiro KidoTomoyuki WatanabeSachiko OtsukiRieko KanzakiHirotsugu MiyoshiToshimichi YasudaYousuke T HorikawaKeiko MukaidaYasuo M TsutsumiPublished in: BioMed research international (2023)
Dantrolene should be given as rapidly as possible once MH has been diagnosed. Beginning treatment at a more normal body temperature can prevent critical elevations associated with a worse prognosis.